Coronary artery disease is the leading cause of death in the world, and heart disease imposes a heavy burden on patients, society and the health care system. Main paths for improvement of cardiovascular health include strategies for optimized prevention, diagnosis and treatment through novel biomarkers, imaging techniques and
experimental and clinical intervention protocols.
The current research program focuses on unsolved and new aspects along the atherosclerotic line: integrating preclinical discovery of possible new causative factors of atherosclerosis, early identification of sublinical cardiovascular disease and finally improved diagnostics and treatment of stable and acute heart disease.
The current research program intends to deliver high quality cardiovascular research using novel biomarkers, coronary computed tomography angiography, cardiac magnetic resonance imaging and cardiac ultrasound. Further, the program uses a translational research approach to introduce novel interventions and medical devices in the diseased heart and better percutaneous and surgical treatment in patients with heart disease.
The current research program was made possible through a generous gift from Trond Mohn Foundation of 15 MNOK.